Identification and use of bacterial [2Fe-2S] dihydroxy-acid dehydratases
First Claim
Patent Images
1. A method for identifying [2Fe-2S] dihydroxy-acid dehydratase (DHAD) enzymes comprising:
- (a) querying one or more amino acid sequences with a Profile Hidden Markov Model prepared using the proteins of SEQ ID NO;
164, 168, 230, 232, 298, 310, 344, and 346, wherein amino acid sequences with an E-value of less than 10−
5 provide a first subset of sequences;
(b) analyzing the first subset of sequences of step (a) for the presence of three conserved cysteines that correspond to positions 56, 129, and 201 in SEQ ID NO;
168, whereby a second subset of sequences is identified;
(c) analyzing the second subset of sequences of step (b) for the presence of signature conserved amino acids at positions corresponding to positions in SEQ ID NO;
168, wherein said amino acids are aspartic acid at position 88, arginine or asparagine at position 142, asparagine at position 208, and leucine at position 454, whereby a third subset of sequences is identified;
(d) expressing a protein having an amino acid sequence identified by step (b) or step (c) in a host cell;
(e) purifying the protein of step (d);
(f) confirming that the protein of step (e) has DHAD activity; and
(g) confirming that the protein of step (f) is a [2Fe-2S] DHAD enzyme by UV-vis and EPR spectroscopy.
3 Assignments
0 Petitions
Accused Products
Abstract
A group of bacterial dihydroxy-acid dehydratases having a [2Fe-2S] cluster was discovered. Bacterial [2Fe-2S] DHADs were expressed as heterologous proteins in bacteria and yeast cells, providing DHAD activity for conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate or 2,3-dihydroxymethylvalerate to α-ketomethylvalerate. Isobutanol and other compounds may be synthesized in pathways that include bacterial [2Fe-2S] DHAD activity.
58 Citations
7 Claims
-
1. A method for identifying [2Fe-2S] dihydroxy-acid dehydratase (DHAD) enzymes comprising:
-
(a) querying one or more amino acid sequences with a Profile Hidden Markov Model prepared using the proteins of SEQ ID NO;
164, 168, 230, 232, 298, 310, 344, and 346, wherein amino acid sequences with an E-value of less than 10−
5 provide a first subset of sequences;(b) analyzing the first subset of sequences of step (a) for the presence of three conserved cysteines that correspond to positions 56, 129, and 201 in SEQ ID NO;
168, whereby a second subset of sequences is identified;(c) analyzing the second subset of sequences of step (b) for the presence of signature conserved amino acids at positions corresponding to positions in SEQ ID NO;
168, wherein said amino acids are aspartic acid at position 88, arginine or asparagine at position 142, asparagine at position 208, and leucine at position 454, whereby a third subset of sequences is identified;(d) expressing a protein having an amino acid sequence identified by step (b) or step (c) in a host cell; (e) purifying the protein of step (d); (f) confirming that the protein of step (e) has DHAD activity; and (g) confirming that the protein of step (f) is a [2Fe-2S] DHAD enzyme by UV-vis and EPR spectroscopy. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification